Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FTY720 (CAS 162359-56-0)

5.0(1)
Write a reviewAsk a question

See product citations (14)

Alternate Names:
Fingolimod
Application:
FTY720 is a cell-permeable immunosuppressive agent
CAS Number:
162359-56-0
Purity:
>98%
Molecular Weight:
343.90
Molecular Formula:
C19H33NO2•HCl
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

FTY720 is an aminopropanediol cell-permeable EDG-1 (endothelial differential gene 1 receptor) antagonist and immunosuppresive agent. It may act to display lymphocyte, or white blood cell, sequestration properties. When FTY720 is phosphorylated, it becomes an agonist for four sphingosine 1-phosphate receptors. FTY720 is an inhibitor of cPLA2.


FTY720 (CAS 162359-56-0) References

  1. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.  |  Mandala, S., et al. 2002. Science. 296: 346-9. PMID: 11923495
  2. The immune modulator FTY720 targets sphingosine 1-phosphate receptors.  |  Brinkmann, V., et al. 2002. J Biol Chem. 277: 21453-7. PMID: 11967257
  3. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity.  |  Brinkmann, V. and Lynch, KR. 2002. Curr Opin Immunol. 14: 569-75. PMID: 12183155
  4. FTY720: a most promising immunosuppressant modulating immune cell functions.  |  Zhang, Z. and Schluesener, HJ. 2007. Mini Rev Med Chem. 7: 845-50. PMID: 17692046
  5. Potential anti-tumor effects of FTY720 associated with PP2A activation: a brief review.  |  Cristóbal, I., et al. 2016. Curr Med Res Opin. 32: 1137-41. PMID: 26950691
  6. The emerging role of FTY720 (Fingolimod) in cancer treatment.  |  White, C., et al. 2016. Oncotarget. 7: 23106-27. PMID: 27036015
  7. Possible regenerative effects of fingolimod (FTY720) in multiple sclerosis disease: An overview on remyelination process.  |  Yazdi, A., et al. 2020. J Neurosci Res. 98: 524-536. PMID: 31385341
  8. Cardioprotective mechanism of FTY720 in ischemia reperfusion injury.  |  Ahmed, N. 2019. J Basic Clin Physiol Pharmacol. 30: PMID: 31469655
  9. FTY720 in CNS injuries: Molecular mechanisms and therapeutic potential.  |  Zhang, L. and Wang, H. 2020. Brain Res Bull. 164: 75-82. PMID: 32846199
  10. The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.  |  Naseh, M., et al. 2021. Brain Behav. 11: e02179. PMID: 33969931
  11. FTY720 induces neutrophil extracellular traps via a NADPH oxidase-independent pathway.  |  Zhang, L., et al. 2021. Arch Biochem Biophys. 711: 109015. PMID: 34437865
  12. The protective role of FTY720 in promoting survival of allograft fat in mice.  |  Yi, Y., et al. 2022. Kaohsiung J Med Sci. 38: 889-896. PMID: 35833419
  13. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.  |  Chiba, K., et al. 1998. J Immunol. 160: 5037-44. PMID: 9590253

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

FTY720, 1 mg

sc-202161
1 mg
$33.00

FTY720, 5 mg

sc-202161A
5 mg
$77.00

FTY720, 25 mg

sc-202161B
25 mg
$120.00